Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
3.340
+0.050 (1.52%)
At close: Jul 31, 2026, 4:00 PM EDT
3.200
-0.140 (-4.19%)
After-hours: Jul 31, 2026, 7:34 PM EDT
Adial Pharmaceuticals Earnings Call Transcripts
Fiscal Year 2026
-
The acquisition brings a novel, colon-targeted therapy for ulcerative colitis and up to $64M in financing, with Azora equity holders gaining majority ownership. The combined company will focus on advancing AT177 through early clinical milestones.